Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000197401 | SCV000270183 | benign | not specified | 2016-07-13 | criteria provided, single submitter | clinical testing | p.Gly528Gly in exon 23 of ELN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.4% (283/66738) o f European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.br oadinstitute.org; dbSNPrs61734584). |
Eurofins Ntd Llc |
RCV000197401 | SCV000341155 | likely benign | not specified | 2016-05-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000260725 | SCV000469924 | likely benign | Cutis laxa, autosomal dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000470810 | SCV000469925 | likely benign | Supravalvar aortic stenosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000470810 | SCV000563050 | benign | Supravalvar aortic stenosis | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001727627 | SCV002497522 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ELN: BP4, BP7 |
Breakthrough Genomics, |
RCV001727627 | SCV005220367 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000197401 | SCV001808013 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727627 | SCV001969986 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530152 | SCV004734614 | benign | ELN-related disorder | 2019-03-27 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |